Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Protamine Sulfate |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Protamine Sulfate
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
Prothrombin Complex Concentrate |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Prothrombin Complex Concentrate
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
Raltitrexed |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Raltitrexed
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Ramosetron |
5-HT3 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Ramosetron
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
||||
Ranimustine |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Ranimustine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Rasburicase |
Cytoprotective / Antidote Agent | Both (Solid & Hematologic) | ||
|
Molecule
Rasburicase
Therapeutic Category
Supportive Care (Chemoprotective/Rescue Agent)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Cytoprotective / Antidote Agent |
||||
Recombinant Activated Factor VII |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Recombinant Activated Factor VII
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
Relugolix |
GnRH Antagonist | Solid Tumour (Prostate) | ||
|
Molecule
Relugolix
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
GnRH Antagonist |
||||
Rintodestrant |
Selective Estrogen Receptor Degrader (SERD) | Solid Tumour (Breast) | ||
|
Molecule
Rintodestrant
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
||||
Risedronate (Onc Adjacent) |
Bisphosphonate | Both (Solid & Hematologic) | ||
|
Molecule
Risedronate (Onc Adjacent)
Therapeutic Category
Bone-Modifying Agent
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Bisphosphonate |
||||
Rivaroxaban |
Anticoagulant (Cancer-Associated Thrombosis) | Both (Solid & Hematologic) | ||
|
Molecule
Rivaroxaban
Therapeutic Category
Supportive Care (Anticoagulant)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anticoagulant (Cancer-Associated Thrombosis) |
||||
Rolapitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Rolapitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Protamine SulfateSupportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|
Prothrombin Complex ConcentrateSupportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|
RaltitrexedCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
RamosetronSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
|
RanimustineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
RasburicaseSupportive Care (Chemoprotective/Rescue Agent) |
|
|
Therapeutic Category
Supportive Care (Chemoprotective/Rescue Agent)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Cytoprotective / Antidote Agent |
|
Recombinant Activated Factor VIISupportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|
RelugolixHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
GnRH Antagonist |
|
RintodestrantHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
|
Risedronate (Onc Adjacent)Bone-Modifying Agent |
|
|
Therapeutic Category
Bone-Modifying Agent
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Bisphosphonate |
|
RivaroxabanSupportive Care (Anticoagulant) |
|
|
Therapeutic Category
Supportive Care (Anticoagulant)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anticoagulant (Cancer-Associated Thrombosis) |
|
RolapitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|